Showing results (261-270 of 538) with videos related to

Sort By:
Pageof 54
Annals of the Rheumatic Diseases|November 1, 2016
2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome: A consensus and data-driven methodology involving three international patient cohortsCaroline H Shiboski, Stephen C Shiboski, Raphaèle Seror, et al.
Arthritis and Rheumatism|June 7, 2013
CCL19, a B cell chemokine, is related to the decrease of blood memory B cells and predicts the clinical response to rituximab in patients with rheumatoid arthritisJérémie Sellam, Stéphanie Rouanet, Houria Hendel-Chavez, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 28, 2016
2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient CohortsCaroline H Shiboski, Stephen C Shiboski, Raphaèle Seror, et al.
Nature Reviews. Disease Primers|May 9, 2020
Immune-related adverse events of checkpoint inhibitorsManuel Ramos-Casals, Julie R Brahmer, Margaret K Callahan, et al.
Clinical Rheumatology|December 15, 2016
Body mass does not impact the clinical response to intravenous abatacept in patients with rheumatoid arthritis. Analysis from the "pan-European registry collaboration for abatacept (PANABA)Florenzo Iannone, Delphine S Courvoisier, Jacques Eric Gottenberg, et al.
Arthritis Research & Therapy|February 26, 2020
Seasonal effect on fatigue, pain and dryness in primary Sjögren's syndromePierre-Marie Duret, Nicolas Meyer, Alain Saraux, et al.
Rheumatology (Oxford, England)|September 19, 2023
Can efficacy and safety data from clinical trials of rituximab in RA be extrapolated? Insights from 1984 patients from the AIR-PR RegistryYann Nguyen, Xavier Mariette, Jacques E Gottenberg, et al.
BMJ Open|June 17, 2025
Abatacept versus tocilizumab for the treatment of rheumatoid arthritis in TNF inhibitor inadequate responders: study protocol of the SUNSTAR randomised controlled open-label superiority trialTristan Pascart, Bruno Fautrel, Jacques-Eric Gottenberg, et al.
Arthritis and Rheumatism|April 13, 2004
Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS)Xavier Mariette, Philippe Ravaud, Serge Steinfeld, et al.
Annals of the Rheumatic Diseases|January 20, 2012
Influence of replacing tuberculin skin test with ex vivo interferon γ release assays on decision to administer prophylactic antituberculosis antibiotics before anti-TNF therapyXavier Mariette, Gabriel Baron, Florence Tubach, et al.
Pageof 54